Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Get practical Zero Based Budgeting insights that help you refine your dollar allocations and boost financial efficiency.
16,266 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
A bold stake move in Hut 8 has sparked a new conversation about concentration, risk, and opportunity in crypto-relate...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
Alibaba’s AI models project sharp upside for XRP, Bitcoin and Ethereum by the end of 2026. The forecasts come as mark...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
Chip stocks are back in the spotlight as AI and data demand push hardware needs higher. This article weighs Micron ag...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...
Lane Generational just disclosed a sizeable stake in Evolv Technologies, signaling potential interest from big invest...
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
This article unpacks the fibk 2026 earnings transcript to reveal what the quarter’s numbers mean for investors. You’l...